Science Explorer Back to mapMap
Discussion

Chemotherapy-induced organ toxicity mitigation

Chemotherapy-induced organ toxicity mitigation is a research topic within Pathology and Forensic Medicine. Science Explorer counts 11k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the mechanisms of cisplatin-induced nephrotoxicity, including oxidative stress, apoptosis, inflammation, and mitochondrial dysfunction. It also explores various renoprotective strategies and potential interventions to mitigate kidney injury caused by cisplatin. The research covers a wide range of topics such as the role of specific antioxidants, inflammatory pathways, and cellular mechanisms involved in chemotherapy-induced kidney damage.

  • Cisplatin
  • Nephrotoxicity
  • Renoprotective Strategies
  • Oxidative Stress
  • Apoptosis
  • Inflammation
  • Mitochondrial Dysfunction
  • Antioxidants
  • Chemotherapy
  • Kidney Injury
Research works
11k
fractional, since 1950
In the world top 10%
1.1k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+17%
the tick is no change
Largest producer
China
28% of the 10 largest, 2022-now
Chemotherapy-induced organ toxicity mitigation
Drawing this view